Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: A multicenter experience of 1499 clinical cases

Bixia Xiang, Hongbo Zhu, Yiping Shen, David T. Miller, Kangmo Lu, Xiaofeng Hu, Hans C. Andersson, Tarachandra M. Narumanchi, Yueying Wang, Jose E. Martinez, Bai Lin Wu, Peining Li, Marilyn M. Li, Tian Jian Chen, Yao-Shan Fan

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

To assess the clinical utility of genome-wide oligonucleotide arrays in diagnosis of mental retardation and to address issues relating to interpretation of copy number changes (CNCs), we collected results on a total of 1499 proband patients from five academic diagnostic laboratories where the same 44K array platform has been used. Three of the five laboratories achieved a diagnostic yield of 14% and the other two had a yield of 11 and 7%, respectively. Approximately 80% of the abnormal cases had a single segment deletion or duplication, whereas the remaining 20% had a compound genomic imbalance involving two or more DNA segments. Deletion of 16p11.2 is a common microdeletion syndrome associated with mental retardation. We classified pathogenic CNCs into six groups according to the structural changes. Our data have demonstrated that the 44K platform provides a reasonable resolution for clinical use and a size of 300 kb can be used as a practical cutoff for further investigations of the clinical relevance of a CNC detected with this platform. We have discussed in depth the issues associated with the clinical use of array CGH and provided guidance for interpretation, reporting, and counseling of test results based on our experience.

Original languageEnglish
Pages (from-to)204-212
Number of pages9
JournalJournal of Molecular Diagnostics
Volume12
Issue number2
DOIs
StatePublished - Mar 1 2010

Fingerprint

Comparative Genomic Hybridization
Oligonucleotide Array Sequence Analysis
Intellectual Disability
Genome
Counseling
DNA

ASJC Scopus subject areas

  • Molecular Medicine
  • Pathology and Forensic Medicine

Cite this

Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation : A multicenter experience of 1499 clinical cases. / Xiang, Bixia; Zhu, Hongbo; Shen, Yiping; Miller, David T.; Lu, Kangmo; Hu, Xiaofeng; Andersson, Hans C.; Narumanchi, Tarachandra M.; Wang, Yueying; Martinez, Jose E.; Wu, Bai Lin; Li, Peining; Li, Marilyn M.; Chen, Tian Jian; Fan, Yao-Shan.

In: Journal of Molecular Diagnostics, Vol. 12, No. 2, 01.03.2010, p. 204-212.

Research output: Contribution to journalArticle

Xiang, B, Zhu, H, Shen, Y, Miller, DT, Lu, K, Hu, X, Andersson, HC, Narumanchi, TM, Wang, Y, Martinez, JE, Wu, BL, Li, P, Li, MM, Chen, TJ & Fan, Y-S 2010, 'Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: A multicenter experience of 1499 clinical cases', Journal of Molecular Diagnostics, vol. 12, no. 2, pp. 204-212. https://doi.org/10.2353/jmoldx.2010.090115
Xiang, Bixia ; Zhu, Hongbo ; Shen, Yiping ; Miller, David T. ; Lu, Kangmo ; Hu, Xiaofeng ; Andersson, Hans C. ; Narumanchi, Tarachandra M. ; Wang, Yueying ; Martinez, Jose E. ; Wu, Bai Lin ; Li, Peining ; Li, Marilyn M. ; Chen, Tian Jian ; Fan, Yao-Shan. / Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation : A multicenter experience of 1499 clinical cases. In: Journal of Molecular Diagnostics. 2010 ; Vol. 12, No. 2. pp. 204-212.
@article{bed59eb710ea448c9e75974fcc69d64f,
title = "Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: A multicenter experience of 1499 clinical cases",
abstract = "To assess the clinical utility of genome-wide oligonucleotide arrays in diagnosis of mental retardation and to address issues relating to interpretation of copy number changes (CNCs), we collected results on a total of 1499 proband patients from five academic diagnostic laboratories where the same 44K array platform has been used. Three of the five laboratories achieved a diagnostic yield of 14{\%} and the other two had a yield of 11 and 7{\%}, respectively. Approximately 80{\%} of the abnormal cases had a single segment deletion or duplication, whereas the remaining 20{\%} had a compound genomic imbalance involving two or more DNA segments. Deletion of 16p11.2 is a common microdeletion syndrome associated with mental retardation. We classified pathogenic CNCs into six groups according to the structural changes. Our data have demonstrated that the 44K platform provides a reasonable resolution for clinical use and a size of 300 kb can be used as a practical cutoff for further investigations of the clinical relevance of a CNC detected with this platform. We have discussed in depth the issues associated with the clinical use of array CGH and provided guidance for interpretation, reporting, and counseling of test results based on our experience.",
author = "Bixia Xiang and Hongbo Zhu and Yiping Shen and Miller, {David T.} and Kangmo Lu and Xiaofeng Hu and Andersson, {Hans C.} and Narumanchi, {Tarachandra M.} and Yueying Wang and Martinez, {Jose E.} and Wu, {Bai Lin} and Peining Li and Li, {Marilyn M.} and Chen, {Tian Jian} and Yao-Shan Fan",
year = "2010",
month = "3",
day = "1",
doi = "10.2353/jmoldx.2010.090115",
language = "English",
volume = "12",
pages = "204--212",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "2",

}

TY - JOUR

T1 - Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation

T2 - A multicenter experience of 1499 clinical cases

AU - Xiang, Bixia

AU - Zhu, Hongbo

AU - Shen, Yiping

AU - Miller, David T.

AU - Lu, Kangmo

AU - Hu, Xiaofeng

AU - Andersson, Hans C.

AU - Narumanchi, Tarachandra M.

AU - Wang, Yueying

AU - Martinez, Jose E.

AU - Wu, Bai Lin

AU - Li, Peining

AU - Li, Marilyn M.

AU - Chen, Tian Jian

AU - Fan, Yao-Shan

PY - 2010/3/1

Y1 - 2010/3/1

N2 - To assess the clinical utility of genome-wide oligonucleotide arrays in diagnosis of mental retardation and to address issues relating to interpretation of copy number changes (CNCs), we collected results on a total of 1499 proband patients from five academic diagnostic laboratories where the same 44K array platform has been used. Three of the five laboratories achieved a diagnostic yield of 14% and the other two had a yield of 11 and 7%, respectively. Approximately 80% of the abnormal cases had a single segment deletion or duplication, whereas the remaining 20% had a compound genomic imbalance involving two or more DNA segments. Deletion of 16p11.2 is a common microdeletion syndrome associated with mental retardation. We classified pathogenic CNCs into six groups according to the structural changes. Our data have demonstrated that the 44K platform provides a reasonable resolution for clinical use and a size of 300 kb can be used as a practical cutoff for further investigations of the clinical relevance of a CNC detected with this platform. We have discussed in depth the issues associated with the clinical use of array CGH and provided guidance for interpretation, reporting, and counseling of test results based on our experience.

AB - To assess the clinical utility of genome-wide oligonucleotide arrays in diagnosis of mental retardation and to address issues relating to interpretation of copy number changes (CNCs), we collected results on a total of 1499 proband patients from five academic diagnostic laboratories where the same 44K array platform has been used. Three of the five laboratories achieved a diagnostic yield of 14% and the other two had a yield of 11 and 7%, respectively. Approximately 80% of the abnormal cases had a single segment deletion or duplication, whereas the remaining 20% had a compound genomic imbalance involving two or more DNA segments. Deletion of 16p11.2 is a common microdeletion syndrome associated with mental retardation. We classified pathogenic CNCs into six groups according to the structural changes. Our data have demonstrated that the 44K platform provides a reasonable resolution for clinical use and a size of 300 kb can be used as a practical cutoff for further investigations of the clinical relevance of a CNC detected with this platform. We have discussed in depth the issues associated with the clinical use of array CGH and provided guidance for interpretation, reporting, and counseling of test results based on our experience.

UR - http://www.scopus.com/inward/record.url?scp=77649121644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649121644&partnerID=8YFLogxK

U2 - 10.2353/jmoldx.2010.090115

DO - 10.2353/jmoldx.2010.090115

M3 - Article

C2 - 20093387

AN - SCOPUS:77649121644

VL - 12

SP - 204

EP - 212

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 2

ER -